BDBM50167763 ((2R,3aS,12bS)-11-Fluoro-2,3,3a,12b-tetrahydro-1,8-dioxa-dibenzo[e,h]azulen-2-ylmethyl)-dimethyl-amine::CHEMBL362950

SMILES: CN(C)C[C@H]1C[C@@H]2[C@H](O1)c1cc(F)ccc1Oc1ccccc21

InChI Key: InChIKey=LGHLMADLDHUIJY-WTANOLMUSA-N

Data: 3 KI

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50167763   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Nociceptin/Orphanin FQ, NOP receptor (RAT)	BDBM50167763 (((2R,3aS,12bS)-11-Fluoro-2,3,3a,12b-tetrahydro-1,8...) Show SMILES CN(C)C[C@H]1C[C@@H]2[C@H](O1)c1cc(F)ccc1Oc1ccccc21 Show InChI InChI=1S/C19H20FNO2/c1-21(2)11-13-10-15-14-5-3-4-6-17(14)23-18-8-7-12(20)9-16(18)19(15)22-13/h3-9,13,15,19H,10-11H2,1-2H3/t13-,15+,19+/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	41	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research & Development Curated by ChEMBL					Assay Description In vitro binding affinity against norepinephrin transpoter using [3H]-nisoxetine as radioligand				Bioorg Med Chem Lett 15: 2898-901 (2005) Article DOI: 10.1016/j.bmcl.2005.03.076 BindingDB Entry DOI: 10.7270/Q29C6X0N
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 2C (Homo sapiens (Human))	BDBM50167763 (((2R,3aS,12bS)-11-Fluoro-2,3,3a,12b-tetrahydro-1,8...) Show SMILES CN(C)C[C@H]1C[C@@H]2[C@H](O1)c1cc(F)ccc1Oc1ccccc21 Show InChI InChI=1S/C19H20FNO2/c1-21(2)11-13-10-15-14-5-3-4-6-17(14)23-18-8-7-12(20)9-16(18)19(15)22-13/h3-9,13,15,19H,10-11H2,1-2H3/t13-,15+,19+/m1/s1	Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	63	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research & Development Curated by ChEMBL					Assay Description In vitro binding affinity against 5-hydroxytryptamine 2C receptor using [3H]-mesulergine as radioligand expressed in CHO cells				Bioorg Med Chem Lett 15: 2898-901 (2005) Article DOI: 10.1016/j.bmcl.2005.03.076 BindingDB Entry DOI: 10.7270/Q29C6X0N
					More data for this Ligand-Target Pair
5-hydroxytryptamine receptor 2A (Homo sapiens (Human))	BDBM50167763 (((2R,3aS,12bS)-11-Fluoro-2,3,3a,12b-tetrahydro-1,8...) Show SMILES CN(C)C[C@H]1C[C@@H]2[C@H](O1)c1cc(F)ccc1Oc1ccccc21 Show InChI InChI=1S/C19H20FNO2/c1-21(2)11-13-10-15-14-5-3-4-6-17(14)23-18-8-7-12(20)9-16(18)19(15)22-13/h3-9,13,15,19H,10-11H2,1-2H3/t13-,15+,19+/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	423	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research & Development Curated by ChEMBL					Assay Description In vitro binding affinity against 5-hydroxytryptamine 2A receptor using [125I]-R91150 as radioligand expressed in L929 cells				Bioorg Med Chem Lett 15: 2898-901 (2005) Article DOI: 10.1016/j.bmcl.2005.03.076 BindingDB Entry DOI: 10.7270/Q29C6X0N
					More data for this Ligand-Target Pair